Joseph Wu
President presso American Heart Association, Inc.
Profilo
Joseph C.
Wu is the founder of Stem Cell Theranostics, Inc. founded in 2013.
He is currently the President & Director at American Heart Association, Inc. Dr. Wu holds a doctorate degree from the University of California, Los Angeles and Yale University.
Posizioni attive di Joseph Wu
| Società | Posizione | Inizio |
|---|---|---|
American Heart Association, Inc.
 American Heart Association, Inc. Miscellaneous Commercial ServicesCommercial Services American Heart Association, Inc. operates a voluntary health organization funded by private contributions. The organization offers services for coronary heart diseases and strokes, high blood cholesterol & physical inactivity, obesity, and diabetes. The company was founded in 1924 and is headquartered in Dallas, TX. | President | - |
Precedenti posizioni note di Joseph Wu
| Società | Posizione | Fine |
|---|---|---|
Stem Cell Theranostics, Inc.
 Stem Cell Theranostics, Inc. BiotechnologyHealth Technology Stem Cell Theranostics, Inc. develops genetically-targeted therapies for genetic and drug-induced heart disease. It offers a discovery platform that focuses on the generation and use of stem cell-derived, patient-specific cardiac models in drug screening and therapeutic development. The company was founded by Andrew Lee, Robert C. Robbins, Divya Nag, and Joseph C. Wu in 2013 and is headquartered in Redwood City, CA. | Founder | - |
Formazione di Joseph Wu
| University of California, Los Angeles | Doctorate Degree |
| Yale University | Doctorate Degree |
Esperienze
Posizioni ricoperte
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 2 |
|---|---|
American Heart Association, Inc.
American Heart Association, Inc. Miscellaneous Commercial ServicesCommercial Services American Heart Association, Inc. operates a voluntary health organization funded by private contributions. The organization offers services for coronary heart diseases and strokes, high blood cholesterol & physical inactivity, obesity, and diabetes. The company was founded in 1924 and is headquartered in Dallas, TX. | Commercial Services |
Stem Cell Theranostics, Inc.
Stem Cell Theranostics, Inc. BiotechnologyHealth Technology Stem Cell Theranostics, Inc. develops genetically-targeted therapies for genetic and drug-induced heart disease. It offers a discovery platform that focuses on the generation and use of stem cell-derived, patient-specific cardiac models in drug screening and therapeutic development. The company was founded by Andrew Lee, Robert C. Robbins, Divya Nag, and Joseph C. Wu in 2013 and is headquartered in Redwood City, CA. | Health Technology |
- Borsa valori
- Insiders
- Joseph Wu
